Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

EU Approves Marketing for Ixekizumab in Adults with PsA

Michele B. Kaufman, PharmD, BCGP  |  February 7, 2018

In its second indication in the EU, ixekizumab has been approved by the European Commission to treat adults with active psoriatic arthritis…

Filed under:ConditionsDrug UpdatesPsoriatic Arthritis Tagged with:EuropeEuropean UnionixekizumabPsoriatic Arthritisskin

Arthritis Crisis: It’s Time to Act

Susan Bernstein  |  February 5, 2018

Funding drives arthritis research breakthroughs and prevention programs, and advocates from the ACR, Arthritis Foundation and the National Recreation and Park Association (NRPA) pitched funding increases to lawmakers at a lunchtime briefing held Feb. 1 in Washington, D.C., in cooperation with the Congressional Arthritis Caucus. During the briefing, titled $300 Billion Crisis: The High Cost…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Arthritis 101Arthritis FoundationCongressional Arthritis CaNational Recreation and Park Asso

ACGME Milestones Debated at ACR: Does the Milestones System Ask too many Questions?

Larry Beresford  |  February 5, 2018

Milestones are at the core of the current system designed to evaluate medical residency and fellowship programs and their participants. But are all milestones meaningful for medical education? This idea was at the center of a debate during the 2017 ACR/ARHP Annual Meeting, during which speakers explored the advantages and drawbacks of using training milestones for rheumatology fellowships…

Filed under:Education & TrainingProfessional Topics Tagged with:2017 ACR/ARHP Annual MeetingACGMEACR/ARHP Annual MeetingEducationgraduate medical educationmilestonesrheumatology

ACR in Action: A Look at ACR Activities That Support Your Practice

Carina Stanton  |  February 1, 2018

Rheumatologists working in every practice setting face a number of challenges that can seem insurmountable. How do you cost-effectively manage administrative burdens? How do you establish an efficient and effective approach to capturing quality metrics? How do you maintain the critical elements of the care you provide, such as diagnostic musculoskeletal ultrasound and patient access…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:ACR advocacybiosimilar pricingdiagnostic MSUSpractice areaspractice supportreducing administrative burdensrheumatology-specific APMRISE registry

RISE Readiness for MIPS in 2018

From the College  |  February 1, 2018

In 2018, all providers will have to submit an entire year’s worth of their quality measure data to the CMS. After 2017, the transition year, the requirements and performance thresholds begin to increase. The CMS is still heavily incentivizing participation in a Qualified Clinical Data Registry (QCDR), such as the RISE registry, for reporting in…

Filed under:From the CollegePractice SupportProfessional TopicsResearch Rheum Tagged with:MIPSQualified Clinical Data Registry (QCDR)quality measure dataRheumatology Informatics System for Effectiveness (RISE) Registry

Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More

Michele B. Kaufman, PharmD, BCGP  |  January 31, 2018

The FDA has designated upadacitinib a breakthrough therapy to treat adults with moderate to severe atopic dermatitis…

Filed under:ConditionsDrug UpdatesPsoriatic Arthritis Tagged with:abataceptAddictionaddiction treatmentbuprenorphineCAM2038Psoriatic ArthritisU.S. Food and Drug Administration (FDA)upadacitinib

Amazon, Berkshire, JPMorgan Partner to Cut U.S. Healthcare Costs

Caroline Humer & David Henry  |  January 30, 2018

NEW YORK (Reuters)—Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. said on Tuesday they will form a company to cut health costs for hundreds of thousands of their employees, setting up a major challenge to an inefficient U.S. healthcare system. The move by three of the best-known U.S. business leaders—Amazon’s Jeff Bezos, Berkshire’s…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Health InsuranceHealthcarehealthcare cost

Service Dogs Aid RA Patients with Mobility, Chores, Companionship & More

Karen Appold  |  January 30, 2018

Patients with severe RA can struggle with walking, getting dressed, carrying items and more, all of which can negatively affect their quality of life. But according to Bharat Kumar, MD, service dogs can help RA patients by providing both physical and emotional support, aiding patient mobility and quality of life…

Filed under:ConditionsRheumatoid Arthritis Tagged with:lifestylepatient carequality of lifeRheumatoid Arthritis (RA)service dogs

EU Approves Certolizumab Pegol for Pregnant & Nursing Patients

Michele B. Kaufman, PharmD, BCGP  |  January 23, 2018

In the EU, certolizumab pegol has been approved for use in pregnant and nursing women with chronic rheumatic disease…

Filed under:Biologics/DMARDsDrug UpdatesResearch Rheum Tagged with:breast milkbreastfeedingCertolizumab PegolEuropean Medicines Agencypregnancypregnant women

E6011 & Tocilizumab Monotherapy Studies Show Promising Results for RA Patients

Michele B. Kaufman, PharmD, BCGP  |  January 19, 2018

New RA Antibody Treatment SAN DIEGO—A recent study examined the pharmacokinetics, safety and efficacy of E6011, an anti-fractalkine monoclonal antibody designed to treat rheumatoid arthritis (RA).1 Researchers presented the results of this first 52-week trial of E6011 at the 2017 ACR/ARHP Annual Meeting in November. Fractalkine (CX3CL1/FKN) is a chemokine that regulates chemo­taxis and adhesion…

Filed under:Drug UpdatesMeeting ReportsResearch Rheum Tagged with:ACR/ARHP Annual MeetingDrugsMethotrexateResearchRheumatoid arthritis

  • « Previous Page
  • 1
  • …
  • 164
  • 165
  • 166
  • 167
  • 168
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences